Cordyceps Sunshine Biotech Holdings (RAJAF) Return on Equity (2023 - 2024)

Cordyceps Sunshine Biotech Holdings (RAJAF) recorded quarterly Return on Equity of 0.01% in Q4 2024, down 71.39% quarter-over-quarter from 0.04% in Q4 2023, and down 3.0% on a YoY basis from 0.01% in Q1 2024.

Cordyceps Sunshine Biotech Holdings (RAJAF) Return on Equity (2023 - 2024) Analysis & Trends

Cordyceps Sunshine Biotech Holdings' Return on Equity history runs 2 years deep, the most recent figure standing at 0.01% for Q4 2024.

  • In Q4 2024, Return on Equity fell 3.0% year-over-year to 0.01%; the TTM figure through Dec 2024 stood at 0.01% (down 3.0% YoY), while the FY2025 annual figure was 0.0%, down 1.0% from the prior year.
  • Return on Equity was 0.01% for Q4 2024 at Cordyceps Sunshine Biotech Holdings, down from 0.04% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.04% in Q4 2023 to a low of 0.01% in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Paranovus Entertainment Technology 12,507.92 Bn 12,507.92 Bn - -
2 Kraft Heinz 27.05 Bn 22.98 Bn 2.22 Bn 0.00%
3 General Mills 17.93 Bn 17.16 Bn 1.37 Bn 0.00%
4 Jbs 13.56 Bn 8.99 Bn 2.32 Bn 0.00%
5 Hormel Foods 13.29 Bn 12.44 Bn 518.51 Mn 0.00%
6 Mccormick 12.45 Bn 12.85 Bn 708.90 Mn 0.00%
7 Magnum Ice Cream 11.94 Bn 11.47 Bn - -
8 J M Smucker 11.83 Bn 11.77 Bn 862.10 Mn 0.00%
9 Smithfield Foods 9.80 Bn 8.73 Bn 511.00 Mn 0.00%
10 Cordyceps Sunshine Biotech Holdings - - - -

Historic Data

Download Data
DateValue
Dec 31, 2024 0.01%
Dec 31, 2023 0.04%
Sep 30, 2023 0.01%